These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9659869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
    George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR.
    Am J Psychiatry; 2000 Nov; 157(11):1835-42. PubMed ID: 11058482
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long term effects of smoking cessation in hospitalized schizophrenia patients.
    Miyauchi M, Kishida I, Suda A, Shiraishi Y, Fujibayashi M, Taguri M, Ishii C, Ishii N, Moritani T, Hirayasu Y.
    BMC Psychiatry; 2017 Mar 07; 17(1):87. PubMed ID: 28270120
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.
    Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, Jansons S, Wilhelm K.
    Am J Psychiatry; 2006 Nov 07; 163(11):1934-42. PubMed ID: 17074945
    [Abstract] [Full Text] [Related]

  • 9. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.
    J Clin Psychopharmacol; 2007 Aug 07; 27(4):380-6. PubMed ID: 17632223
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Counseling and exercise intervention for smoking reduction in patients with schizophrenia: a feasibility study.
    Bernard PP, Esseul EC, Raymond L, Dandonneau L, Xambo JJ, Carayol MS, Ninot GJ.
    Arch Psychiatr Nurs; 2013 Feb 07; 27(1):23-31. PubMed ID: 23352022
    [Abstract] [Full Text] [Related]

  • 12. Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients.
    Prikryl R, Ustohal L, Kucerova HP, Kasparek T, Jarkovsky J, Hublova V, Vrzalova M, Ceskova E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar 03; 49():30-5. PubMed ID: 24211840
    [Abstract] [Full Text] [Related]

  • 13. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E, Ball MP, Buchholz AS, Gold JM, Evins AE, McMahon RP, Buchanan RW.
    J Clin Psychiatry; 2012 Jan 03; 73(1):95-102. PubMed ID: 21535998
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effects of tobacco on antipsychotic treatments and their symptoms in schizophrenia].
    Bouhlel S, Jones Y, Msolly M, Ben Hawala S, El-Hechmi Z.
    Tunis Med; 2012 Apr 03; 90(4):311-5. PubMed ID: 22535346
    [Abstract] [Full Text] [Related]

  • 18. Implementation of a personalized workplace smoking cessation programme.
    Paul CL, McLennan J, Baxendale A, Schnelle B, Rawson J, Turon HE, Tzelepis F.
    Occup Med (Lond); 2013 Dec 03; 63(8):568-74. PubMed ID: 24213092
    [Abstract] [Full Text] [Related]

  • 19. [Combined modality therapeutic program for the control of smoking].
    Lara Cantú MA, Oñate Rivadeneyra G, Balzaretti González M, Sánchez Martínez R.
    Acta Psiquiatr Psicol Am Lat; 1984 Sep 03; 30(3):193-200. PubMed ID: 6395633
    [Abstract] [Full Text] [Related]

  • 20. Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study.
    Gelkopf M, Noam S, Rudinski D, Lerner A, Behrbalk P, Bleich A, Melamed Y.
    J Nerv Ment Dis; 2012 Feb 03; 200(2):142-6. PubMed ID: 22297311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.